We are live on
!
Find out more
BBA
BLB&B Advisors Portfolio holdings
AUM
$2.42B
1-Year Est. Return
22.12%
This Fund
S&P 500
This Quarter
Est. Return
+13.11%
1 Year Est. Return
+22.12%
3 Year Est. Return
+60.69%
5 Year Est. Return
+64.73%
10 Year Est. Return
+215.43%
AUM
$850M
AUM Growth
+$122M
(+17%)
Cap. Flow
+$31.1M
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
30.1%
Holding
286
New
14
Increased
81
Reduced
142
Closed
9
Top Buys
| 1 |
LPT
Liberty Property Trust
LPT
|
+$7.12M |
| 2 |
Schwab US Mid-Cap ETF
SCHM
|
+$5.28M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.02M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.82M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$3.39M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.05M |
| 2 |
Kraft Heinz
KHC
|
+$1.54M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$998K |
| 4 |
Kimberly-Clark
KMB
|
+$845K |
| 5 |
Cisco
CSCO
|
+$825K |
Sector Composition
| 1 | Technology | 12.88% |
| 2 | Healthcare | 11.72% |
| 3 | Industrials | 7.63% |
| 4 | Financials | 7.52% |
| 5 | Consumer Staples | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Stryker
SYK
$127B
| $1.1M | 0.13% |
5,586
-1,010
| -15% | -$182K |
|
127
United Parcel Service
UPS
$99.6B
| $1.1M | 0.13% |
9,834
-1,218
| -11% | -$129K |
|
128
Ecolab
ECL
$77.6B
| $1.09M | 0.13% |
6,183
-1,530
| -20% | -$249K |
|
129
PayPal
PYPL
$50B
| $1.08M | 0.13% |
10,416
+1,489
| +17% | +$141K |
|
130
Baxter International
BAX
$12.1B
| $1.08M | 0.13% |
13,285
-350
| -3% | -$25.5K |
|
131
iShares MSCI EAFE ETF
EFA
$76.9B
| $1.07M | 0.13% |
16,553
-1,014
| -6% | -$63.9K |
|
132
iShares MSCI Emerging Markets ETF
EEM
$28.4B
| $1.02M | 0.12% |
23,871
-6,044
| -20% | -$254K |
|
133
Outfront Media
OUT
$5.88B
| $1.01M | 0.12% |
43,745
-548
| -1% | -$11.5K |
|
134
Digital Realty Trust
DLR
$64.2B
| $994K | 0.12% |
8,353
-2,715
| -25% | -$303K |
|
135
PPG Industries
PPG
$26.5B
| $922K | 0.11% |
8,170
+1,323
| +19% | +$142K |
|
136
Air Products & Chemicals
APD
$66.2B
| $916K | 0.11% |
4,795
+475
| +11% | +$81.8K |
|
|
RTN
137
DELISTED
Raytheon Company
RTN
| $908K | 0.11% |
4,987
| – | – |
|
138
Lockheed Martin
LMT
$118B
| $907K | 0.11% |
3,021
+425
| +16% | +$125K |
|
139
Weyerhaeuser
WY
$17.6B
| $892K | 0.1% |
33,848
+4,707
| +16% | +$119K |
|
140
Schwab U.S Small- Cap ETF
SCHA
$22.8B
| $883K | 0.1% |
50,508
| – | – |
|
141
Medtronic
MDT
$107B
| $873K | 0.1% |
9,584
+2,611
| +37% | +$234K |
|
142
Eli Lilly
LLY
$1.04T
| $870K | 0.1% |
6,702
-425
| -6% | -$51.7K |
|
143
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.4B
| $837K | 0.1% |
2,423
-631
| -21% | -$212K |
|
144
Cigna
CI
$75.1B
| $815K | 0.1% |
5,067
-107
| -2% | -$19.5K |
|
145
Annaly Capital Management
NLY
$17.2B
| $795K | 0.09% |
19,900
-3,485
| -15% | -$142K |
|
146
Eastman Chemical
EMN
$7.91B
| $792K | 0.09% |
10,434
-50
| -0.5% | -$3.97K |
|
147
Exelon
EXC
$47.9B
| $791K | 0.09% |
22,135
-905
| -4% | -$30.8K |
|
148
Amgen
AMGN
$201B
| $790K | 0.09% |
4,156
-1,000
| -19% | -$191K |
|
|
SJI
149
DELISTED
South Jersey Industries, Inc.
SJI
| $788K | 0.09% |
24,582
-835
| -3% | -$25.3K |
|
150
Kohl's
KSS
$1.98B
| $781K | 0.09% |
11,359
-641
| -5% | -$43.5K |
|
Similar funds
PUI
SCM
VF
GIA
KFA
PA
LIM
SOAM
BLB&B Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, BLB&B Advisors held 286 positions worth $850M, up 17% from $728M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
BLB&B Advisors deployed $31.1M of net new capital in Q1 2019, opening 14 new positions and adding to 81 existing holdings. Its largest new stake was Liberty Property Trust: 152,971 shares worth $7.41M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.05M trimmed.
- BLB&B Advisors's largest Q1 2019 buy was Liberty Property Trust: 152,971 shares worth $7.41M.
- BLB&B Advisors added most to Schwab US Mid-Cap ETF in Q1 2019, an estimated $5.28M increase.
- BLB&B Advisors's biggest Q1 2019 reduction was Ionis Pharmaceuticals, cutting an estimated $4.05M.
- BLB&B Advisors fully exited Biogen in Q1 2019, selling an estimated $360K.
- BLB&B Advisors's ten largest holdings make up 30% of its $850M portfolio in Q1 2019.
- BLB&B Advisors opened 14 new positions and closed 9 in Q1 2019.
- BLB&B Advisors's portfolio value rose 17% quarter-over-quarter to $850M.
Based on BLB&B Advisors's 13F filing for Q1 2019, filed 19 Apr 2019.